News

Outcome Capital Advises Whisker Labs in the Sale of its Energy Management Business to Resideo Technologies

Outcome Capital Advises Whisker Labs in the Sale of its Energy Management Business to Resideo Technologies May 29, 2019, Reston, VA Outcome Capital, an investment...

Read More
News

Outcome Capital Announces Meridian Bioscience Has Acquired GenePOC

Outcome Capital Announces Meridian Bioscience Has Acquired GenePOC May 1, 2019, BOSTON, MA –(BUSINESS WIRE)– Outcome Capital, a specialized investment banking firm that serves middle...

Read More
News

BIO18: Pfizer’s Bourla on Volume vs. Value & a Little Dealmaking Advice from Outcome Capital

Partnerships and the move to value dominated the chatter at the BIO International Convention's 25th annual partnering meeting on Monday in the life science hub of Boston.

Read More
News

Active VCs vs. Zombies: Dysfunctional Boards That Mess With M&A

Investors want to know: Will Big Pharma go bargain hunting, do a little M&A? Will it lift my biotech portfolio out of the gutter? Multiple factors are always at work. At the most basic level, pharma still needs to acquire new products to stay afloat. Little biotechs who create things need to be acquired, or go public, to reward their investors. Those facts never change. But there’s another powerful, and dark, force creating havoc in many biotech boardrooms. People who have witnessed it don’t like to talk about it. When they do, it’s in hushed tones...

Read More
News

Outcome Capital sells operating division of East West Mortgage to Bankrate

On August 4, 2006, Outcome Capital announced that it had acted as exclusive financial advisor to East West Mortgage on the sale of three websites...

Read More

Contact Us for More Information

Would you like to learn more about working with Outcome Capital or discuss your specific needs?

Contact Us

  • Boston

    20 Custom House St, Suite 1200, Boston, MA 02110
    (617) 431-2278